180 related articles for article (PubMed ID: 29257799)
1. Expression of Coiled-Coil Domain Containing 34 (CCDC34) and its Prognostic Significance in Pancreatic Adenocarcinoma.
Qi W; Shao F; Huang Q
Med Sci Monit; 2017 Dec; 23():6012-6018. PubMed ID: 29257799
[TBL] [Abstract][Full Text] [Related]
2. High Expression of CCDC34 Is Associated with Poor Survival in Cervical Cancer Patients.
Liu LB; Huang J; Zhong JP; Ye GL; Xue L; Zhou MH; Huang G; Li SJ
Med Sci Monit; 2018 Nov; 24():8383-8390. PubMed ID: 30458457
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Coiled-Coil Domain-Containing Protein 34 (CCDC34) and its Correlation with Angiogenesis in Esophageal Squamous Cell Carcinoma.
Hu DD; Li PC; He YF; Jia W; Hu B
Med Sci Monit; 2018 Feb; 24():698-705. PubMed ID: 29397026
[TBL] [Abstract][Full Text] [Related]
4. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of CCDC34 in colorectal cancer and its involvement in tumor growth, apoptosis and invasion.
Geng W; Liang W; Fan Y; Ye Z; Zhang L
Mol Med Rep; 2018 Jan; 17(1):465-473. PubMed ID: 29115580
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer.
Wang OH; Azizian N; Guo M; Capello M; Deng D; Zang F; Fry J; Katz MH; Fleming JB; Lee JE; Wolff RA; Hanash S; Wang H; Maitra A
PLoS One; 2016; 11(3):e0152300. PubMed ID: 27023625
[TBL] [Abstract][Full Text] [Related]
7. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
8. Molecular Analysis of Vascular Endothelial Growth Factor (VEGF) Receptors in EUS-guided Samples Obtained from Patients with Pancreatic Adenocarcinoma.
Costache MI; Iordache S; Costache CA; Dragos E; Dragos A; Saftoiu A
J Gastrointestin Liver Dis; 2017 Mar; 26(1):51-57. PubMed ID: 28338114
[TBL] [Abstract][Full Text] [Related]
9. Martrilin-3 (MATN3) Overexpression in Gastric Adenocarcinoma and its Prognostic Significance.
Wu PL; He YF; Yao HH; Hu B
Med Sci Monit; 2018 Jan; 24():348-355. PubMed ID: 29343680
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast activation protein and its prognostic significance in correlation with vascular endothelial growth factor in pancreatic adenocarcinoma.
Patsouras D; Papaxoinis K; Kostakis A; Safioleas MC; Lazaris AC; Nicolopoulou-Stamati P
Mol Med Rep; 2015 Jun; 11(6):4585-90. PubMed ID: 25625587
[TBL] [Abstract][Full Text] [Related]
11. The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma.
Huang C; Huang R; Chang W; Jiang T; Huang K; Cao J; Sun X; Qiu Z
Neoplasma; 2012; 59(1):52-61. PubMed ID: 22082308
[TBL] [Abstract][Full Text] [Related]
12. The Expression and Survival Significance of Glucose Transporter-1 in Pancreatic Cancer: Meta-Analysis, Bioinformatics Analysis and Retrospective Study.
Du J; Gu J; Deng J; Kong L; Guo Y; Jin C; Bao Y; Fu D; Li J
Cancer Invest; 2021 Oct; 39(9):741-755. PubMed ID: 34229540
[TBL] [Abstract][Full Text] [Related]
13. The clinical significance of FRAT1 and ABCG2 expression in pancreatic ductal adenocarcinoma.
Yuan Y; Yang Z; Miao X; Li D; Liu Z; Zou Q
Tumour Biol; 2015 Dec; 36(12):9961-8. PubMed ID: 26178481
[TBL] [Abstract][Full Text] [Related]
14. High expression of TROP2 correlates with poor prognosis in pancreatic cancer.
Fong D; Moser P; Krammel C; Gostner JM; Margreiter R; Mitterer M; Gastl G; Spizzo G
Br J Cancer; 2008 Oct; 99(8):1290-5. PubMed ID: 18813308
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma.
Zheng J; Huang S; Huang Y; Song L; Yin Y; Kong W; Chen X; Ouyang X
Tumour Biol; 2016 Jun; 37(6):7853-9. PubMed ID: 26695153
[TBL] [Abstract][Full Text] [Related]
16. Arpin downregulation is associated with poor prognosis in pancreatic ductal adenocarcinoma.
Zhang SR; Li H; Wang WQ; Jin W; Xu JZ; Xu HX; Wu CT; Gao HL; Li S; Li TJ; Zhang WH; Xu SS; Ni QX; Yu XJ; Liu L
Eur J Surg Oncol; 2019 May; 45(5):769-775. PubMed ID: 30416079
[TBL] [Abstract][Full Text] [Related]
17. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X
Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197
[TBL] [Abstract][Full Text] [Related]
18. High expression of S100A11 in pancreatic adenocarcinoma is an unfavorable prognostic marker.
Xiao MB; Jiang F; Ni WK; Chen BY; Lu CH; Li XY; Ni RZ
Med Oncol; 2012 Sep; 29(3):1886-91. PubMed ID: 21912994
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma.
Zhang JT; Lin YC; Xiao BF; Yu BT
Med Sci Monit; 2019 Jun; 25():4264-4272. PubMed ID: 31175804
[TBL] [Abstract][Full Text] [Related]
20. BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis.
Huang Y; Zheng J; Tan T; Song L; Huang S; Zhang Y; Lin L; Liu J; Zheng P; Chen X; Chen X; Ouyang X
Int J Biol Markers; 2018 May; 33(2):189-194. PubMed ID: 29076521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
